Does MEPOLIZUMAB Cause Haemoptysis? 449 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 449 reports of Haemoptysis have been filed in association with MEPOLIZUMAB (Nucala). This represents 1.0% of all adverse event reports for MEPOLIZUMAB.
449
Reports of Haemoptysis with MEPOLIZUMAB
1.0%
of all MEPOLIZUMAB reports
71
Deaths
244
Hospitalizations
How Dangerous Is Haemoptysis From MEPOLIZUMAB?
Of the 449 reports, 71 (15.8%) resulted in death, 244 (54.3%) required hospitalization, and 140 (31.2%) were considered life-threatening.
Is Haemoptysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 449 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Haemoptysis?
RIVAROXABAN (1,961)
ASPIRIN (1,255)
APIXABAN (846)
TREPROSTINIL (838)
ALBUTEROL (652)
CLOPIDOGREL BISULFATE (643)
PREDNISONE (618)
WARFARIN (555)
ADALIMUMAB (472)
TIOTROPIUM (462)
Which MEPOLIZUMAB Alternatives Have Lower Haemoptysis Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE